Prescriptions for the anti-parasite medication ivermectin doubled in the months following an endorsement by a celebrity during a high-profile podcast as an off-label cancer treatment, a UCLA-led study […]
EAHP Congress Highlights The timing of immunotherapy administration influences treatment effectiveness, with morning treatment associated with significantly better survival outcomes, according to new real-world data presented at the […]
EAHP Congress Highlights Continuous piperacillin/tazobactam infusion via elastomeric pump offers a safe, cost-effective alternative to inpatient antibiotic therapy in paediatric oncology, with measurable benefits for ward capacity, healthcare […]
A cancer diagnosis can upend any life. For young adults already navigating a step into independence, it can be especially distressing. But there are few evidence-based interventions to […]
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings. Fortunately, several […]
A new study funded by the National Cancer Institute at the National Institutes of Health finds that how high school students perceive the costs of sun protection and the rewards of tanning […]
Researchers have already shown that mild to moderate exercise can reduce “chemo brain,” and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can […]
Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050. Similarly, yearly deaths […]
Researchers report that patients diagnosed with cancer who subsequently develop a mental disorder are at an increased risk of all-cause death. The findings were published on Feb. 23, […]
The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased […]
Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mixed benefits for patients while costing Medicare billions of […]
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed alternative […]
ADVERTISMENT
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
